Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 21
- Registration Number
- NCT01646580
Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure
Phase 4
Terminated
- Conditions
- Compensated Heart Failure
- Interventions
- Drug: torasemide-PRDrug: Furosemide-IRDrug: torasemide-IR
- First Posted Date
- 2012-03-09
- Last Posted Date
- 2013-04-25
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 8
- Registration Number
- NCT01549158
- Locations
- 🇪🇸
Centre d'Investigació de Medicaments (CIM), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Phase 3
Completed
- Conditions
- Impetigo
- Interventions
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 465
- Registration Number
- NCT01397461
- Locations
- 🇩🇪
Georg Popp, Augsburg, Germany
🇩🇪Roland Aschoff, Dresden, Germany
🇩🇪Diamant Thaci, Frankfurt/Main, Germany
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Phase 2
Terminated
- Conditions
- Elevated LDL Cholesterol
- Interventions
- Drug: Simvastatin, ramipril, acetylsalicylic acid
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2013-04-24
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 107
- Registration Number
- NCT01362218
- Locations
- 🇪🇸
Hospital Clinic, Barcelona, Spain
Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment
Phase 2
Completed
- Conditions
- Vulvovaginal Candidiasis
- Interventions
- Drug: placebo
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2013-10-09
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 229
- Registration Number
- NCT01144286
- Locations
- 🇪🇸
Ferrer Internacional S.A., Barcelona, Spain
Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions
Phase 2
Completed
- Conditions
- Secondarily Infected Traumatic Lesions
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2010-06-09
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 200
- Registration Number
- NCT01005771
- Locations
- 🇩🇪
Dermatologische Praxis, Mahlow, Germany
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
Phase 2
Terminated
- Conditions
- Elevated LDL Cholesterol
- Interventions
- Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),
- First Posted Date
- 2009-10-30
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 36
- Registration Number
- NCT01004705
- Locations
- 🇺🇸
Mount Sinai Medical Center, New York, New York, United States
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
- First Posted Date
- 2009-10-30
- Last Posted Date
- 2012-07-26
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 38
- Registration Number
- NCT01005290
- Locations
- 🇺🇸
Mount Sinai Medical Center, New York, New York, United States
Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.
Phase 4
Completed
- Conditions
- Congestive Heart Failure
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2009-07-15
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 142
- Registration Number
- NCT00409942
- Locations
- 🇪🇸
Central Hospital, Oviedo, Asturias, Spain
🇪🇸Canet de Mar, Primary Care Centre, Canet de Mar, Barcelona, Spain
🇪🇸Centelles - Primar Care Centre, Centellas, Barcelona, Spain
Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
Phase 4
Completed
- Conditions
- Hypertension
- First Posted Date
- 2006-06-07
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 388
- Registration Number
- NCT00334386